Skip to content. | Skip to navigation

Personal tools
Sections
You are here: Home topics Pharmaceuticals Guidance to help pharma companies prepare for Brexit

Guidance to help pharma companies prepare for Brexit

— filed under: ,

The European Medicines Agency (EMA) has published additional guidance to help pharmaceutical companies prepare for the United Kingdom’s (UK) withdrawal from the European Union (EU). The guidance document outlines the practical and simplified requirements that companies should follow when they apply for changes to their marketing authorisation to allow for the continued marketing of their medicine in the European Economic Area after the UK withdraws from the EU. The guidance has been prepared on the basis that the UK will become a third country as of 30 March 2019.

The link address is: http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500239369

Document Actions